EMERGING SCIENCE IN THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA

PFIZER, S.A

Objecte

Topic: Acute Myeloid Leukemia.

Destination: Aid through which Pfizer will finance programs for the training of health professionals on advances in the treatment of Acute Myeloid Leukemia (AML) in patients not suitable for intensive chemotherapy, with the aim of helping these professionals in making decisions for evidence-based treatment.

Budget: 15 months.

Duration: $150,000.

Are you interested in this call?

Estàs interessat?

Omple el següent formulari per rebre més informació: